Medicare Enrolled
Dr. Phillip Amodeo, M.D.
Neurology · Brunswick, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amodeo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amodeo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amodeo
Dr. Phillip Amodeo is a neurology specialist in Brunswick, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Amodeo performed 872 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Amodeo received a total of $35,087 from 68 pharmaceutical and/or device companies across 731 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amodeo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 31% volume in GA
$35,087 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗872
Medicare services
Top 31% in GA for neurology
Not available
Unique patients (not deduplicated)
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
182 | $118 | $240 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $85 | $180 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 94 | $190 | $437 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
91 | $90 | $209 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $128 | $341 |
| New patient office visit, complex (60-74 min) | 68 | $154 | $338 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $60 | $142 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
36 | $165 | $566 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
29 | $101 | $549 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
25 | $72 | $207 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
20 | $42 | $139 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $107 | $263 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
16 | $24 | $80 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
14 | $36 | $162 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$35,087
Total received (2018-2024)
Avg $5,012/year across 7 years
Top 11% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
731
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,425
2023
$1,978
2022
$1,762
2021
$15,549
2020
$6,184
2019
$1,878
2018
$5,310
Payments by company (2024)
ABBVIE INC.
$371
Alexion Pharmaceuticals, Inc.
$217
Lundbeck LLC
$206
ARGENX US, INC.
$176
Teva Pharmaceuticals USA, Inc.
$147
PFIZER INC.
$141
SK Life Science, Inc.
$122
EMD Serono, Inc.
$120
Kyowa Kirin, Inc.
$85
CSL Behring
$85
Genentech USA, Inc.
$82
Novartis Pharmaceuticals Corporation
$77
Mallinckrodt Hospital Products Inc.
$77
Neurelis, Inc.
$72
Otsuka America Pharmaceutical, Inc.
$68
UCB, Inc.
$60
Sumitomo Pharma America, Inc.
$53
TG Therapeutics, Inc.
$47
Lilly USA, LLC
$42
MITSUBISHI TANABE PHARMA AMERICA, INC.
$42
Vanda Pharmaceuticals Inc.
$25
Biogen, Inc.
$21
ACADIA Pharmaceuticals Inc
$20
Medtronic, Inc.
$19
Merz Pharmaceuticals, LLC
$18
Amgen Inc.
$16
Eisai Inc.
$15
Top 3 companies account for 32.8% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$12,235
Allergan, Inc.
$8,131
Supernus Pharmaceuticals, Inc.
$3,031
Novartis Pharmaceuticals Corporation
$608
ABBVIE INC.
$581
Adamas Pharmaceuticals, Inc.
$542
UCB, Inc.
$531
Alexion Pharmaceuticals, Inc.
$496
EMD Serono, Inc.
$494
Amgen Inc.
$461
Genentech USA, Inc.
$421
Biogen, Inc.
$392
CSL Behring
$391
Lilly USA, LLC
$367
Avanir Pharmaceuticals, Inc.
$365
Lundbeck LLC
$346
Teva Pharmaceuticals USA, Inc.
$335
GENZYME CORPORATION
$320
SK Life Science, Inc.
$312
Kyowa Kirin, Inc.
$303
PFIZER INC.
$299
Medtronic Vascular, Inc.
$283
ACADIA Pharmaceuticals Inc
$252
Upsher-Smith Laboratories LLC
$209
ARGENX US, INC.
$199
Mallinckrodt Hospital Products Inc.
$195
Eisai Inc.
$169
Sumitomo Pharma America, Inc.
$167
Sunovion Pharmaceuticals Inc.
$161
Otsuka America Pharmaceutical, Inc.
$160
Neurocrine Biosciences, Inc.
$158
EISAI INC.
$157
Neurelis, Inc.
$146
Grifols USA, LLC
$145
Acorda Therapeutics, Inc
$137
Biohaven Pharmaceuticals, Inc.
$122
MITSUBISHI TANABE PHARMA AMERICA, INC.
$120
Mitsubishi Tanabe Pharma America, Inc.
$112
Biohaven Pharmaceutical Holding Company Ltd.
$110
Allergan Inc.
$88
JAZZ PHARMACEUTICALS INC.
$86
US WorldMeds, LLC
$81
IMPEL PHARMACEUTICALS INC.
$74
Assertio Therapeutics, Inc.
$70
Mallinckrodt LLC
$53
Bayer HealthCare Pharmaceuticals Inc.
$49
Abbott Laboratories
$49
TG Therapeutics, Inc.
$47
Horizon Therapeutics plc
$46
GE HEALTHCARE
$42
Janssen Pharmaceuticals, Inc
$41
Marinus Pharmaceuticals, Inc.
$35
Medtronic, Inc.
$34
Amylyx Pharmaceuticals, Inc.
$33
Promius Pharma LLC
$31
Egalet US Inc
$30
Alnylam Pharmaceuticals Inc.
$28
Vanda Pharmaceuticals Inc.
$25
Mallinckrodt Enterprises LLC
$23
Azurity Pharmaceuticals, Inc.
$22
Aprecia Pharmaceuticals, LLC
$22
E.R. Squibb & Sons, L.L.C.
$20
PORTOLA PHARMACEUTICALS, INC.
$19
Merz Pharmaceuticals, LLC
$18
ARBOR PHARMACEUTICALS, INC.
$16
Avion Pharmaceuticals
$15
Zyla Life Sciences
$14
Bausch Health US, LLC
$14
Top 3 companies account for 66.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · Radicava · Rebif · Reveal LINQ · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · Xadago · Xeomin · ZEPOSIA · ZORVOLEX · ZTALMY · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
4
County median income
$68,546
Nearest hospital to ZIP centroid (approximate)
SOUTHEAST GEORGIA HEALTH SYSTEM- BRUNSWICK CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amodeo is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amodeo experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Amodeo performed 182 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Amodeo receive payments from pharmaceutical companies?
Yes. Dr. Amodeo received a total of $35,087 from 68 companies across 731 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amodeo's costs compare to other neurologists in Brunswick?
Dr. Amodeo's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amodeo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Brunswick
Browse neurologists in Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology